Shanghai, China

Qiangang Zheng

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Qiangang Zheng: Innovator in Pharmaceutical Chemistry

Introduction

Qiangang Zheng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases. With a total of six patents to his name, Zheng's work is recognized for its innovative approach to drug development.

Latest Patents

Zheng's latest patents include the "Spiro aromatic ring compound and use thereof." This patent provides a compound of formula I or a pharmaceutically acceptable salt, enantiomer, diastereomer, tautomer, solvate, isotopic substituent, polymorph, prodrug, or metabolite thereof. The compound of formula I exhibits higher inhibitory activity against SHP2, making it a potential candidate for preventing or treating diseases related to SHP2. Another patent, "Spiro aromatic ring compound and application thereof," shares similar details and emphasizes the compound's therapeutic potential.

Career Highlights

Throughout his career, Qiangang Zheng has worked with notable companies in the pharmaceutical industry. He has been associated with Etern Biopharma (Shanghai) Co., Ltd. and Novartis AG, where he has contributed to various research and development projects. His expertise in creating innovative compounds has positioned him as a valuable asset in the field.

Collaborations

Zheng has collaborated with several professionals in his field, including Ming Xu and Jing Li. These collaborations have further enhanced his research capabilities and have led to the successful development of his patented compounds.

Conclusion

Qiangang Zheng's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in drug development and treatment options for diseases related to SHP2.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…